Interleukin-12/23 monoclonal antibody for psoriasis
Okamoto, H.; Momohara, S.
New England Journal of Medicine 356(19): 2003
2007
ISSN/ISBN: 0028-4793 PMID: 17494940 Document Number: 607031
Document emailed within 1 workday
Related Documents
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684Balashova, T.A.; Pashkov, V.S.; Onoprienko, L.V.; Mikhaleva, I.I.; Mareeva, T.I.; Petrova, E.E.; Nesmeianov, V.A.; Ivanov, V.T. 1991: Study of the interaction of the monoclonal antibody to human interleukin-2 and its Fab-fragment with synthetic peptides --interleukin-2 fragments by (1)H-NMR Bioorganicheskaia Khimiia 17(11): 1470-1486
Hiesse, C.; Lantz, O.; Kriaa, F.; Noury, J.; Fries, D.; Charpentier, B.; Bazin, H. 1991: Treatment with Lo-Tact-1, a monoclonal antibody to the interleukin-2 receptor, in kidney transplantation Presse Medicale 20(40): 2036-2038
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Gramatzki, M.; Burger, R.; Strobel, G.; Trautmann, U.; Bartram, C.R.; Helm, G.; Horneff, G.; Alsalameh, S.; Jonker, M.; Gebhart, E. 1995: Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness Leukemia 9(3): 382-390
Volk, H.D.; Brocke, S.; Osawa, H.; Diamantstein, T. 1986: Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice Clinical and Experimental Immunology 66(1): 126-131
Morgan, A.C.; Sullivan, W.; Graves, S.; Woodhouse, C.S. 1989: Murine monoclonal IgG3 to human colorectal tumor-associated antigens: enhancement of antibody-dependent cell-mediated cytotoxicity by interleukin 2 Cancer Research 49(10): 2773-2776
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Cahn, J.Y.; Bordigoni, P.; Tiberghien, P.; Milpied, N.; Brion, A.; Widjenes, J.; Lioure, B.; Michel, G.; Burdach, S.; Kolb, H.J. 1995: Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. a multicenter phase IIi study Transplantation 60(9): 939-942
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Shinkura, H.; Imazeki, I.; Yamazaki, M.; Oda, Y.; Kotoh, M.; Mihara, M. 1998: In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates Anticancer Research 18(2a): 1217-1221
Chen, Z.; Colon, I.; Ortiz, N.; Callister, M.; Dong, G.; Pegram, M.Y.; Arosarena, O.; Strome, S.; Nicholson, J.C.; Van Waes, C. 1998: Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines Cancer Research 58(16): 3668-3676
Ward, L.D.; Shi, P.T.; Simpson, R.J. 1992: Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance Biochemistry International 26(3): 559-565
Vento, S.; Salpietro, V.; Giordano, L.; Ugliola, M.; Costa, G.M.; Cavaciocchi, P.; Russomanno, E. 1983: Benign monoclonal gammopathies: probable antibody specificity of monoclonal immunoglobulins Minerva Medica 74(41): 2439-2445
Scopsi, L.; Bock, E.; Larsson, L.I. 1986: Monoclonal antibody immunocytochemistry: novel method extending usefulness of monoclonal antibodies for antigen visualization European Journal of Cell Biology 41(1): 97-101
Douillard, J.Y.; Laborda, J.; Burg, C.; Ridge, J.; Levenbook, I.; Blottière, H.; Sela, B.; Hoffman, T.; Ben Ami, S. 1989: Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors Cancer Research 49(3): 687-692
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Kawata, A.; Yoshida, M.; Okazaki, M.; Yokota, S.; Barcos, M.; Seon, B.K. 1994: Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody Cancer Research 54(10): 2688-2694
Ruibal, A.; Pombo, L.; Soriano, A.; Lamiquiz, A. 1988: Quantitative increase of carcinoembryonic antigen (CEA) MARIA (monoclonal antibody radioimmunoassay) in relation to monoclonal CEA in colorectal cancer Medicina Clinica 90(18): 756
Primus, F.J.; Finch, M.D.; Masci, A.M.; Schlom, J.; Kashmiri, S.V. 1993: Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes Cancer Research 53(14): 3355-3361